Literature DB >> 22994620

Delayed onset and prolonged interictal delirium following electroconvulsive therapy.

Arun G Selvaraj1, Samir Kumar Praharaj.   

Abstract

Electroconvulsive therapy is safe and effective in the treatment of depression in older individuals. Minor cognitive side effects of electroconvulsive therapy include acute postictal confusion and reversible short-term memory deficits. However, interictal delirium is uncommon in absence of risk factors. Herein, we report the case a depressed male patient without any known risk factors who developed interictal delirium 2 days after his sixth electroconvulsive therapy session. Interictal delirium improved with treatment within 1 week.
© 2012 The Authors. Psychogeriatrics © 2012 Japanese Psychogeriatric Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22994620     DOI: 10.1111/j.1479-8301.2012.00419.x

Source DB:  PubMed          Journal:  Psychogeriatrics        ISSN: 1346-3500            Impact factor:   2.440


  5 in total

1.  The Role of Acetylcholinesterase Inhibitors in the Treatment of Prolonged Postelectroconvulsive Therapy Delirium.

Authors:  Brianna Gutowski; Emily Bomasang-Layno
Journal:  Case Rep Psychiatry       Date:  2022-05-30

2.  Delayed Onset and Prolonged ECT-Related Delirium.

Authors:  Sameer Hassamal; Ananda Pandurangi; Vasu Venkatachalam; James Levenson
Journal:  Case Rep Psychiatry       Date:  2013-09-03

3.  Prolonged Post-electroconvulsive Therapy Delirium: An Unusual Presentation.

Authors:  Ahmad R Khan; Hafsa Mahmood; Saad Wasiq; Hina Saeed
Journal:  Cureus       Date:  2018-08-28

4.  Factors associated with post-electroconvulsive therapy delirium: A retrospective chart review study.

Authors:  Young Tak Jo; Sung Woo Joo; Jungsun Lee; Yeon Ho Joo
Journal:  Medicine (Baltimore)       Date:  2021-04-09       Impact factor: 1.817

5.  Rivastigmine for ECT-induced cognitive adverse effects in late life depression (RECALL study): A multicenter, randomized, double blind, placebo-controlled, cross-over trial in patients with depression aged 55 years or older: Rationale, objectives and methods.

Authors:  Marieke J Henstra; Thomas C Feenstra; Rob M Kok; Harm-Pieter Spaans; Eric van Exel; Annemiek Dols; Mardien Oudega; Anton C M Vergouwen; Adriano van der Loo; Pierre M Bet; Stephan A Loer; Merijn Eikelenboom; Pascal Sienaert; Simon Lambrichts; Filip Bouckaert; Judith E Bosmans; Nathalie van der Velde; Aartjan T F Beekman; Max L Stek; Didi Rhebergen
Journal:  Front Psychiatry       Date:  2022-07-15       Impact factor: 5.435

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.